Edwards Stock Analysis

Edwards Stock Analysis Notes

About 87.0% of the company shares are held by institutions such as insurance companies. The company had not issued any dividends in recent years. Edwards Lifesciences Corp had 3:1 split on the 1st of June 2020. Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California. Edwards Lifesciences operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 15700 people. To learn more about Edwards Lifesciences Corp call Michael Mussallem at 949 250-2500 or check out www.edwards.com.

Edwards Lifesciences Corp Investment Alerts

Edwards Lifesciences Corp Upcoming and Recent Events

Edwards Largest EPS Surprises

View All Earnings EstimatesView All Earnings Estimates

Edwards Lifesciences SEC Filings

Edwards Lifesciences Thematic Classifications

Edwards Stock Institutional Investors

Note, although Edwards Lifesciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Edwards Market Capitalization

The company currently falls under 'Large-Cap' category with a market capitalization of 49.13 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Edwards Lifesciences's market, we take the total number of its shares issued and multiply it by Edwards Lifesciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Edwards Profitablity

The company has Net Profit Margin (PM) of 0.28 %, which suggests that even a small decline in it sales will erase profits and may result in a net loss, or a negative profit margin. This is way below average. Likewise, it shows Net Operating Margin (NOM) of 0.33 %, which signifies that for every $100 of sales, it has a net operating income of $0.33.

Management Efficiency

The entity has Return on Asset (ROA) of 0.1334 % which means that for every $100 of asset, it generated profit of $0.1334. This is way below average. Likewise, it shows return on total equity (ROE) of 0.2614 %, which means that it produced $0.2614 on every 100 dollars invested by current stockholders. Edwards Lifesciences management efficiency ratios could be used to measure how well edwards lifesciences corp manages its routine affairs as well as how well it operates its assets and liabilities. Edwards Lifesciences Return on Average Assets are fairly stable at the moment as compared to the past year. Edwards Lifesciences reported Return on Average Assets of 0.18 in 2022. Return on Invested Capital is likely to climb to 0.34 in 2023, whereas Return on Investment is likely to drop 25.11 in 2023. Edwards Lifesciences Tax Assets are fairly stable at the moment as compared to the past year. Edwards Lifesciences reported Tax Assets of 484 Million in 2022. Revenue to Assets is likely to climb to 0.75 in 2023, whereas Current Assets are likely to drop slightly above 3 B in 2023.

Technical Drivers

Edwards Lifesciences Corp Price Movement Analysis

Edwards Lifesciences Corp Insider Trading Activities

Edwards Lifesciences Outstanding Bonds

Edwards Lifesciences Predictive Daily Indicators

Edwards Lifesciences Forecast Models

Edwards Lifesciences time-series forecasting models is one of many Edwards Lifesciences' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Edwards Lifesciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Edwards Lifesciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Edwards shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Edwards Lifesciences. By using and applying Edwards Stock analysis, traders can create a robust methodology for identifying Edwards entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Edwards analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Edwards analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Edwards Lifesciences Corp stock analysis indicators help investors evaluate how Edwards Lifesciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Edwards Lifesciences shares will generate the highest return on investment. By understating and applying Edwards Lifesciences stock analysis, traders can identify Edwards Lifesciences position entry and exit signals to maximize returns.

Check out Investing Opportunities. For more information on how to buy Edwards Stock please use our How to Invest in Edwards Lifesciences guide. You can also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

When running Edwards Lifesciences Corp price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.

Is Edwards Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Edwards Lifesciences. If investors know Edwards will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Edwards Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Edwards Lifesciences Corp is measured differently than its book value, which is the value of Edwards that is recorded on the company's balance sheet. Investors also form their own opinion of Edwards Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Edwards Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Edwards Lifesciences' market value can be influenced by many factors that don't directly affect Edwards Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Edwards Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Edwards Lifesciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Edwards Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.